BioMelbourne Network
Progressing BioIndustry
BioDiem Ltd
Website Address:
http://www.biodiem.com
Corporate Member:
Mr David Ballieu
Manager of Legal and Administration
Company Profile:
BioDiem Ltd (ASX:BDM) is an Australian listed company with a focus on commercialising world-class research for vaccines, infectious diseases and other therapeutics areas.
The following projects are currently under development:
1. Live Attenuated Influenza Vaccine (LAIV)
LAIV is an intranasal vaccine for both pandemic and seasonal influenza, with the advantages of breadth of protection and cell culture manufacture. The technology is outlicenced to Nobilon/Schering Plough and is in clinical trials.
2. Retinal Eye Disease Treatment (BDM-E)
BDM-E is a peptide for retinal eye diseases. It has novel and potentially beneficial activity on cell layers in the back of the eye for diseases which are major causes of blindness.
